PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86 | +24.6% | 60,699 | +1.3% | 0.00% | – |
Q2 2023 | $69 | +4.5% | 59,899 | -4.8% | 0.00% | – |
Q1 2023 | $66 | -23.3% | 62,899 | +11.1% | 0.00% | – |
Q4 2022 | $86 | -99.9% | 56,639 | +1.8% | 0.00% | – |
Q3 2022 | $117,000 | +56.0% | 55,653 | -1.1% | 0.00% | – |
Q2 2022 | $75,000 | -35.9% | 56,253 | +0.6% | 0.00% | – |
Q1 2022 | $117,000 | -43.5% | 55,890 | -0.0% | 0.00% | – |
Q4 2021 | $207,000 | -26.6% | 55,892 | -1.4% | 0.00% | -100.0% |
Q3 2021 | $282,000 | -24.4% | 56,684 | -1.0% | 0.00% | 0.0% |
Q2 2021 | $373,000 | -4.4% | 57,284 | +1.1% | 0.00% | 0.0% |
Q1 2021 | $390,000 | -32.3% | 56,670 | +0.2% | 0.00% | -50.0% |
Q4 2020 | $576,000 | +188.0% | 56,550 | -1.0% | 0.00% | +100.0% |
Q3 2020 | $200,000 | -29.8% | 57,150 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $285,000 | +46.9% | 57,300 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $194,000 | – | 57,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |